Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease

BACKGROUND: Leptomeningeal spread in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations who experience disease progression on TKIs portends a poor prognosis. Mutation profiling of tumour DNA in cerebrospinal fluid (CSF) samples can be used to determine...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thorac Dis
Asıl Yazarlar: Arulananda, Surein, Do, Hongdo, Rivalland, Gareth, Loh, Zoe, Musafer, Ashan, Lau, Eddie, Mitchell, Paul, Dobrovic, Alexander, John, Thomas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6588760/
https://ncbi.nlm.nih.gov/pubmed/31285867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.05.41
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller